Deferasirox Tablet
Product Images NDC 73190-052

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 73190-052). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (052 30)

The text provides information about AVKARE Deferasirox Tablets in film-coated form with a dosage of 360 mg per tablet. It includes instructions for storage, dosage, and precautions for keeping the medication out of reach of children. The manufacturer is AVKARE in Pulaski, TN, and the tablets are manufactured by MSN Pharmaceuticals in Piscataway, NJ. The packaging contains 30 tablets and is for prescription use only.*

FDA Label Image

Figure (Deferasirox Figure)

This text provides data on the change in liver iron content, serum ferritin levels, and deferasirox dose in a research study involving a sample size of different individuals. The measurements include milligrams of iron per gram of dry weight for liver iron content, micrograms per liter for serum ferritin levels, and milligrams per kilogram per day for deferasirox dose. The data is structured in a table format, with varying sample sizes for each measurement category.*

FDA Label Image

Structure (Deferasirox Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.